Jubilant Flame International, Ltd.

Overview

• Jurisdiction and offices: Nevada-registered company with principal executive offices listed in Shanghai, China.
• Core business history: Began as a web development and marketing firm; later marketed cosmetics (Acropass) in the United States (ceased in 2020). Since 2020, the company has pursued technical services related to development of nutrition-related products and remains pre-revenue for those activities.
• Current focus: Technical support services for development of nutrition foods (for example, Organic Sprouting Powder) marketed to U.S. customers. No revenue was recognized for fiscal years 2026 or 2025.
• Public market: Common stock traded on OTCQB under the ticker JFIL. The company reported there is no established public market for the shares. As of February 28, 2026, there were 19,985,708 shares outstanding and 79 record holders.
• Employees: Five.

Business model and history

• 1999–2018: Provided web development and marketing services through a wholly owned subsidiary; that subsidiary was disposed of in 2012.
• 2018–2020: Renamed Jubilant Flame and marketed Acropass cosmetic products in the U.S., sourced from Rubyfield Holdings Limited (China). Activities were governed by a Resale Agreement with Rubyfield and a Master Service Agreement with a Manager responsible for branding, social media, advertising, and operation of the company’s online shopping platform (including the Amazon account).
• 2020: Marketing and sales of Acropass products in the U.S. ceased.
• 2020–present: Shifted to providing technical support services for the development of nutrition-related products for U.S. customers. This line remained pre-revenue through fiscal years 2026 and 2025.

Products and suppliers

• Former product offerings (ceased 2020): Acropass Trouble Care (acne treatment) and Acropass Ageless Lifter (wrinkle treatment). These were hydrocolloid patches with dissolving microstructures containing hyaluronic acid and epidermal growth factor.
• Principal supplier during the Acropass period: Rubyfield Holdings Limited (China). The Resale Agreement with Rubyfield expired December 31, 2019, and was not renewed.
• Intellectual property: The company does not own the Acropass IP and does not hold licenses related to Acropass or Rubyfield. The company does own promotional materials created for Acropass (videos, photos, marketing materials).
• Current services: Technical services related to nutrition foods provided under a Master Service Agreement with a Manager who handles branding, social media, ad campaigns, and online platform management for U.S. sales. No revenue was recognized from these services in 2026 or 2025.

Market presence

• Operated an online sales channel (acropass-shop.com) and used social media marketing (Facebook, Instagram, Twitter) during the Acropass period. The company did not operate brick-and-mortar stores. The current service line remains pre-revenue.

Employees and governance

• Employees: Five.
• Directors and officers: Yan Li (President, CEO, Director); Lei Wang (CFO, Director); Kecheng Xu (Secretary/Treasurer, Director); Brian Cheng (Director).
• Governance: The company does not have independent directors or a separate audit committee. The auditor’s report for prior periods identified material weaknesses in internal controls.

Financial snapshot (fiscal years ended February 28)

• Revenue: $0 for 2026 and 2025.
• Net loss:
  • 2026: $(63,507)
  • 2025: $(59,672)
• Operating expenses (general and administrative): $63,507 (2026); $59,672 (2025).
• Cash flows:
  • Cash used in operating activities: $(49,261) (2026); $(69,819) (2025).
  • Cash from financing activities: $52,211 (2026); $69,699 (2025) — proceeds related to related-party loans.
  • Net change in cash: $2,950 (2026); $(120) (2025).
  • Beginning/Ending cash: $1,225 / $4,175 (2026); $1,345 / $1,225 (2025).
• Balance sheet highlights (as of February 28):
  • Total current assets: $16,190 (both years).
  • Total current liabilities: $1,436,282 (2026); $1,369,510 (2025).
  • Working capital deficit: $(1,420,092) (2026); $(1,356,585) (2025).
  • Total liabilities: $1,436,282 (2026); $1,369,510 (2025).
  • Stockholders’ deficit: $(1,420,092) (2026).
    • Common stock: 19,985,708 shares issued and outstanding; $19,986 stated value.
    • Additional paid-in capital: $2,469,045.
    • Accumulated deficit: $(3,909,123).
• Other balance sheet notes:
  • Related party balances (as of February 28, 2026): Accounts payable – related parties $47,643; Accrued officer compensation $535,500; Loan payable – related party $815,635.
  • The company is dependent on advances from related parties for liquidity.
  • Management reported substantial doubt about the company’s ability to continue as a going concern and identified potential plans for additional funding from related parties or equity/debt financing.

Key risks

• Going concern: The auditor flagged substantial doubt about the company’s ability to continue as a going concern.
• Revenue and profitability: The current nutrition-services line remains pre-revenue, and the company recorded net losses in 2026 and 2025.
• Related-party dependence: Financing and certain services are provided by related parties, including the CEO and affiliated entities.
• Governance structure: The company lacks independent directors and a separate audit or compensation committee.